nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—BCHE—Cisplatin—testicular cancer	0.202	0.465	CbGbCtD
Rivastigmine—CYP3A4—Ifosfamide—testicular cancer	0.0631	0.145	CbGbCtD
Rivastigmine—CYP2D6—Vinblastine—testicular cancer	0.0526	0.121	CbGbCtD
Rivastigmine—CYP3A4—Vinblastine—testicular cancer	0.0335	0.0771	CbGbCtD
Rivastigmine—CYP2D6—Doxorubicin—testicular cancer	0.0323	0.0745	CbGbCtD
Rivastigmine—CYP3A4—Etoposide—testicular cancer	0.0302	0.0695	CbGbCtD
Rivastigmine—CYP3A4—Doxorubicin—testicular cancer	0.0206	0.0474	CbGbCtD
Rivastigmine—Haemorrhage—Epirubicin—testicular cancer	0.00022	0.000389	CcSEcCtD
Rivastigmine—Hepatitis—Epirubicin—testicular cancer	0.00022	0.000389	CcSEcCtD
Rivastigmine—Eye disorder—Methotrexate—testicular cancer	0.00022	0.000388	CcSEcCtD
Rivastigmine—Tinnitus—Methotrexate—testicular cancer	0.000219	0.000388	CcSEcCtD
Rivastigmine—Hypoaesthesia—Epirubicin—testicular cancer	0.000219	0.000387	CcSEcCtD
Rivastigmine—Asthenia—Cisplatin—testicular cancer	0.000219	0.000386	CcSEcCtD
Rivastigmine—Pharyngitis—Epirubicin—testicular cancer	0.000218	0.000386	CcSEcCtD
Rivastigmine—Cardiac disorder—Methotrexate—testicular cancer	0.000218	0.000386	CcSEcCtD
Rivastigmine—Sweating—Doxorubicin—testicular cancer	0.000218	0.000384	CcSEcCtD
Rivastigmine—Urinary tract disorder—Epirubicin—testicular cancer	0.000217	0.000384	CcSEcCtD
Rivastigmine—Oedema peripheral—Epirubicin—testicular cancer	0.000217	0.000383	CcSEcCtD
Rivastigmine—Haematuria—Doxorubicin—testicular cancer	0.000216	0.000382	CcSEcCtD
Rivastigmine—Connective tissue disorder—Epirubicin—testicular cancer	0.000216	0.000382	CcSEcCtD
Rivastigmine—Urethral disorder—Epirubicin—testicular cancer	0.000216	0.000381	CcSEcCtD
Rivastigmine—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000215	0.000379	CcSEcCtD
Rivastigmine—Epistaxis—Doxorubicin—testicular cancer	0.000214	0.000378	CcSEcCtD
Rivastigmine—Angiopathy—Methotrexate—testicular cancer	0.000213	0.000377	CcSEcCtD
Rivastigmine—Sinusitis—Doxorubicin—testicular cancer	0.000213	0.000376	CcSEcCtD
Rivastigmine—Visual impairment—Epirubicin—testicular cancer	0.000212	0.000375	CcSEcCtD
Rivastigmine—Mediastinal disorder—Methotrexate—testicular cancer	0.000212	0.000375	CcSEcCtD
Rivastigmine—Chills—Methotrexate—testicular cancer	0.000211	0.000373	CcSEcCtD
Rivastigmine—Nausea—Ifosfamide—testicular cancer	0.00021	0.000371	CcSEcCtD
Rivastigmine—Diarrhoea—Cisplatin—testicular cancer	0.000208	0.000368	CcSEcCtD
Rivastigmine—Erythema multiforme—Epirubicin—testicular cancer	0.000208	0.000368	CcSEcCtD
Rivastigmine—Alopecia—Methotrexate—testicular cancer	0.000208	0.000367	CcSEcCtD
Rivastigmine—Bradycardia—Doxorubicin—testicular cancer	0.000207	0.000366	CcSEcCtD
Rivastigmine—Mental disorder—Methotrexate—testicular cancer	0.000206	0.000364	CcSEcCtD
Rivastigmine—Eye disorder—Epirubicin—testicular cancer	0.000206	0.000364	CcSEcCtD
Rivastigmine—Hypersensitivity—Etoposide—testicular cancer	0.000206	0.000363	CcSEcCtD
Rivastigmine—Tinnitus—Epirubicin—testicular cancer	0.000205	0.000363	CcSEcCtD
Rivastigmine—Malnutrition—Methotrexate—testicular cancer	0.000205	0.000362	CcSEcCtD
Rivastigmine—Erythema—Methotrexate—testicular cancer	0.000205	0.000362	CcSEcCtD
Rivastigmine—Haemoglobin—Doxorubicin—testicular cancer	0.000205	0.000362	CcSEcCtD
Rivastigmine—Flushing—Epirubicin—testicular cancer	0.000204	0.000361	CcSEcCtD
Rivastigmine—Cardiac disorder—Epirubicin—testicular cancer	0.000204	0.000361	CcSEcCtD
Rivastigmine—Rhinitis—Doxorubicin—testicular cancer	0.000204	0.000361	CcSEcCtD
Rivastigmine—Haemorrhage—Doxorubicin—testicular cancer	0.000204	0.00036	CcSEcCtD
Rivastigmine—Hepatitis—Doxorubicin—testicular cancer	0.000204	0.00036	CcSEcCtD
Rivastigmine—Hypoaesthesia—Doxorubicin—testicular cancer	0.000203	0.000358	CcSEcCtD
Rivastigmine—Pharyngitis—Doxorubicin—testicular cancer	0.000202	0.000357	CcSEcCtD
Rivastigmine—Urinary tract disorder—Doxorubicin—testicular cancer	0.000201	0.000355	CcSEcCtD
Rivastigmine—Oedema peripheral—Doxorubicin—testicular cancer	0.000201	0.000355	CcSEcCtD
Rivastigmine—Dysgeusia—Methotrexate—testicular cancer	0.000201	0.000354	CcSEcCtD
Rivastigmine—Asthenia—Etoposide—testicular cancer	0.0002	0.000354	CcSEcCtD
Rivastigmine—Connective tissue disorder—Doxorubicin—testicular cancer	0.0002	0.000354	CcSEcCtD
Rivastigmine—Angiopathy—Epirubicin—testicular cancer	0.0002	0.000353	CcSEcCtD
Rivastigmine—Urethral disorder—Doxorubicin—testicular cancer	0.0002	0.000353	CcSEcCtD
Rivastigmine—Mediastinal disorder—Epirubicin—testicular cancer	0.000198	0.000351	CcSEcCtD
Rivastigmine—Back pain—Methotrexate—testicular cancer	0.000198	0.00035	CcSEcCtD
Rivastigmine—Chills—Epirubicin—testicular cancer	0.000198	0.000349	CcSEcCtD
Rivastigmine—Pruritus—Etoposide—testicular cancer	0.000197	0.000349	CcSEcCtD
Rivastigmine—Arrhythmia—Epirubicin—testicular cancer	0.000197	0.000347	CcSEcCtD
Rivastigmine—Visual impairment—Doxorubicin—testicular cancer	0.000196	0.000347	CcSEcCtD
Rivastigmine—Alopecia—Epirubicin—testicular cancer	0.000195	0.000344	CcSEcCtD
Rivastigmine—Vomiting—Cisplatin—testicular cancer	0.000194	0.000342	CcSEcCtD
Rivastigmine—Vision blurred—Methotrexate—testicular cancer	0.000193	0.000341	CcSEcCtD
Rivastigmine—Mental disorder—Epirubicin—testicular cancer	0.000193	0.000341	CcSEcCtD
Rivastigmine—Erythema multiforme—Doxorubicin—testicular cancer	0.000193	0.00034	CcSEcCtD
Rivastigmine—Rash—Cisplatin—testicular cancer	0.000192	0.000339	CcSEcCtD
Rivastigmine—Dermatitis—Cisplatin—testicular cancer	0.000192	0.000339	CcSEcCtD
Rivastigmine—Malnutrition—Epirubicin—testicular cancer	0.000192	0.000339	CcSEcCtD
Rivastigmine—Erythema—Epirubicin—testicular cancer	0.000192	0.000339	CcSEcCtD
Rivastigmine—Diarrhoea—Etoposide—testicular cancer	0.000191	0.000337	CcSEcCtD
Rivastigmine—Eye disorder—Doxorubicin—testicular cancer	0.00019	0.000336	CcSEcCtD
Rivastigmine—Ill-defined disorder—Methotrexate—testicular cancer	0.00019	0.000336	CcSEcCtD
Rivastigmine—Tinnitus—Doxorubicin—testicular cancer	0.00019	0.000336	CcSEcCtD
Rivastigmine—Anaemia—Methotrexate—testicular cancer	0.000189	0.000334	CcSEcCtD
Rivastigmine—Flushing—Doxorubicin—testicular cancer	0.000189	0.000334	CcSEcCtD
Rivastigmine—Cardiac disorder—Doxorubicin—testicular cancer	0.000189	0.000334	CcSEcCtD
Rivastigmine—Flatulence—Epirubicin—testicular cancer	0.000189	0.000334	CcSEcCtD
Rivastigmine—Tension—Epirubicin—testicular cancer	0.000188	0.000332	CcSEcCtD
Rivastigmine—Dysgeusia—Epirubicin—testicular cancer	0.000188	0.000332	CcSEcCtD
Rivastigmine—Nervousness—Epirubicin—testicular cancer	0.000186	0.000329	CcSEcCtD
Rivastigmine—Back pain—Epirubicin—testicular cancer	0.000185	0.000328	CcSEcCtD
Rivastigmine—Angiopathy—Doxorubicin—testicular cancer	0.000185	0.000327	CcSEcCtD
Rivastigmine—Malaise—Methotrexate—testicular cancer	0.000185	0.000326	CcSEcCtD
Rivastigmine—Dizziness—Etoposide—testicular cancer	0.000184	0.000326	CcSEcCtD
Rivastigmine—Muscle spasms—Epirubicin—testicular cancer	0.000184	0.000326	CcSEcCtD
Rivastigmine—Vertigo—Methotrexate—testicular cancer	0.000184	0.000325	CcSEcCtD
Rivastigmine—Mediastinal disorder—Doxorubicin—testicular cancer	0.000184	0.000324	CcSEcCtD
Rivastigmine—Chills—Doxorubicin—testicular cancer	0.000183	0.000323	CcSEcCtD
Rivastigmine—Arrhythmia—Doxorubicin—testicular cancer	0.000182	0.000322	CcSEcCtD
Rivastigmine—Nausea—Cisplatin—testicular cancer	0.000181	0.00032	CcSEcCtD
Rivastigmine—Vision blurred—Epirubicin—testicular cancer	0.000181	0.000319	CcSEcCtD
Rivastigmine—Alopecia—Doxorubicin—testicular cancer	0.00018	0.000318	CcSEcCtD
Rivastigmine—Cough—Methotrexate—testicular cancer	0.000179	0.000316	CcSEcCtD
Rivastigmine—Mental disorder—Doxorubicin—testicular cancer	0.000178	0.000315	CcSEcCtD
Rivastigmine—Ill-defined disorder—Epirubicin—testicular cancer	0.000178	0.000314	CcSEcCtD
Rivastigmine—Convulsion—Methotrexate—testicular cancer	0.000177	0.000314	CcSEcCtD
Rivastigmine—Vomiting—Etoposide—testicular cancer	0.000177	0.000313	CcSEcCtD
Rivastigmine—Erythema—Doxorubicin—testicular cancer	0.000177	0.000313	CcSEcCtD
Rivastigmine—Malnutrition—Doxorubicin—testicular cancer	0.000177	0.000313	CcSEcCtD
Rivastigmine—Anaemia—Epirubicin—testicular cancer	0.000177	0.000313	CcSEcCtD
Rivastigmine—Agitation—Epirubicin—testicular cancer	0.000176	0.000311	CcSEcCtD
Rivastigmine—Rash—Etoposide—testicular cancer	0.000176	0.000311	CcSEcCtD
Rivastigmine—Dermatitis—Etoposide—testicular cancer	0.000176	0.000311	CcSEcCtD
Rivastigmine—Headache—Etoposide—testicular cancer	0.000175	0.000309	CcSEcCtD
Rivastigmine—Flatulence—Doxorubicin—testicular cancer	0.000175	0.000309	CcSEcCtD
Rivastigmine—Arthralgia—Methotrexate—testicular cancer	0.000174	0.000308	CcSEcCtD
Rivastigmine—Chest pain—Methotrexate—testicular cancer	0.000174	0.000308	CcSEcCtD
Rivastigmine—Myalgia—Methotrexate—testicular cancer	0.000174	0.000308	CcSEcCtD
Rivastigmine—Tension—Doxorubicin—testicular cancer	0.000174	0.000307	CcSEcCtD
Rivastigmine—Dysgeusia—Doxorubicin—testicular cancer	0.000174	0.000307	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000173	0.000306	CcSEcCtD
Rivastigmine—Malaise—Epirubicin—testicular cancer	0.000173	0.000305	CcSEcCtD
Rivastigmine—Discomfort—Methotrexate—testicular cancer	0.000172	0.000304	CcSEcCtD
Rivastigmine—Nervousness—Doxorubicin—testicular cancer	0.000172	0.000304	CcSEcCtD
Rivastigmine—Vertigo—Epirubicin—testicular cancer	0.000172	0.000304	CcSEcCtD
Rivastigmine—Syncope—Epirubicin—testicular cancer	0.000172	0.000304	CcSEcCtD
Rivastigmine—Back pain—Doxorubicin—testicular cancer	0.000172	0.000303	CcSEcCtD
Rivastigmine—Muscle spasms—Doxorubicin—testicular cancer	0.00017	0.000301	CcSEcCtD
Rivastigmine—Palpitations—Epirubicin—testicular cancer	0.000169	0.000299	CcSEcCtD
Rivastigmine—Confusional state—Methotrexate—testicular cancer	0.000169	0.000298	CcSEcCtD
Rivastigmine—Loss of consciousness—Epirubicin—testicular cancer	0.000168	0.000298	CcSEcCtD
Rivastigmine—Cough—Epirubicin—testicular cancer	0.000167	0.000295	CcSEcCtD
Rivastigmine—Vision blurred—Doxorubicin—testicular cancer	0.000167	0.000295	CcSEcCtD
Rivastigmine—Convulsion—Epirubicin—testicular cancer	0.000166	0.000293	CcSEcCtD
Rivastigmine—Infection—Methotrexate—testicular cancer	0.000166	0.000293	CcSEcCtD
Rivastigmine—Nausea—Etoposide—testicular cancer	0.000166	0.000293	CcSEcCtD
Rivastigmine—Hypertension—Epirubicin—testicular cancer	0.000165	0.000292	CcSEcCtD
Rivastigmine—Ill-defined disorder—Doxorubicin—testicular cancer	0.000165	0.000291	CcSEcCtD
Rivastigmine—Nervous system disorder—Methotrexate—testicular cancer	0.000164	0.00029	CcSEcCtD
Rivastigmine—Anaemia—Doxorubicin—testicular cancer	0.000164	0.00029	CcSEcCtD
Rivastigmine—Thrombocytopenia—Methotrexate—testicular cancer	0.000164	0.000289	CcSEcCtD
Rivastigmine—Chest pain—Epirubicin—testicular cancer	0.000163	0.000288	CcSEcCtD
Rivastigmine—Arthralgia—Epirubicin—testicular cancer	0.000163	0.000288	CcSEcCtD
Rivastigmine—Myalgia—Epirubicin—testicular cancer	0.000163	0.000288	CcSEcCtD
Rivastigmine—Agitation—Doxorubicin—testicular cancer	0.000163	0.000288	CcSEcCtD
Rivastigmine—Anxiety—Epirubicin—testicular cancer	0.000163	0.000287	CcSEcCtD
Rivastigmine—Skin disorder—Methotrexate—testicular cancer	0.000162	0.000287	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000162	0.000286	CcSEcCtD
Rivastigmine—Hyperhidrosis—Methotrexate—testicular cancer	0.000162	0.000285	CcSEcCtD
Rivastigmine—Discomfort—Epirubicin—testicular cancer	0.000161	0.000285	CcSEcCtD
Rivastigmine—Malaise—Doxorubicin—testicular cancer	0.00016	0.000283	CcSEcCtD
Rivastigmine—Dry mouth—Epirubicin—testicular cancer	0.00016	0.000282	CcSEcCtD
Rivastigmine—Vertigo—Doxorubicin—testicular cancer	0.000159	0.000281	CcSEcCtD
Rivastigmine—Anorexia—Methotrexate—testicular cancer	0.000159	0.000281	CcSEcCtD
Rivastigmine—Syncope—Doxorubicin—testicular cancer	0.000159	0.000281	CcSEcCtD
Rivastigmine—Confusional state—Epirubicin—testicular cancer	0.000158	0.000279	CcSEcCtD
Rivastigmine—Palpitations—Doxorubicin—testicular cancer	0.000157	0.000277	CcSEcCtD
Rivastigmine—Oedema—Epirubicin—testicular cancer	0.000156	0.000276	CcSEcCtD
Rivastigmine—Hypotension—Methotrexate—testicular cancer	0.000156	0.000276	CcSEcCtD
Rivastigmine—Loss of consciousness—Doxorubicin—testicular cancer	0.000156	0.000275	CcSEcCtD
Rivastigmine—Infection—Epirubicin—testicular cancer	0.000155	0.000275	CcSEcCtD
Rivastigmine—Cough—Doxorubicin—testicular cancer	0.000155	0.000273	CcSEcCtD
Rivastigmine—Shock—Epirubicin—testicular cancer	0.000154	0.000272	CcSEcCtD
Rivastigmine—Convulsion—Doxorubicin—testicular cancer	0.000154	0.000271	CcSEcCtD
Rivastigmine—Nervous system disorder—Epirubicin—testicular cancer	0.000153	0.000271	CcSEcCtD
Rivastigmine—Thrombocytopenia—Epirubicin—testicular cancer	0.000153	0.000271	CcSEcCtD
Rivastigmine—Hypertension—Doxorubicin—testicular cancer	0.000153	0.000271	CcSEcCtD
Rivastigmine—Tachycardia—Epirubicin—testicular cancer	0.000153	0.00027	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000152	0.000269	CcSEcCtD
Rivastigmine—Skin disorder—Epirubicin—testicular cancer	0.000152	0.000268	CcSEcCtD
Rivastigmine—Hyperhidrosis—Epirubicin—testicular cancer	0.000151	0.000267	CcSEcCtD
Rivastigmine—Insomnia—Methotrexate—testicular cancer	0.000151	0.000267	CcSEcCtD
Rivastigmine—Chest pain—Doxorubicin—testicular cancer	0.000151	0.000267	CcSEcCtD
Rivastigmine—Arthralgia—Doxorubicin—testicular cancer	0.000151	0.000267	CcSEcCtD
Rivastigmine—Myalgia—Doxorubicin—testicular cancer	0.000151	0.000267	CcSEcCtD
Rivastigmine—Anxiety—Doxorubicin—testicular cancer	0.00015	0.000266	CcSEcCtD
Rivastigmine—Paraesthesia—Methotrexate—testicular cancer	0.00015	0.000265	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.00015	0.000265	CcSEcCtD
Rivastigmine—Discomfort—Doxorubicin—testicular cancer	0.000149	0.000264	CcSEcCtD
Rivastigmine—Anorexia—Epirubicin—testicular cancer	0.000149	0.000263	CcSEcCtD
Rivastigmine—Dyspnoea—Methotrexate—testicular cancer	0.000149	0.000263	CcSEcCtD
Rivastigmine—Somnolence—Methotrexate—testicular cancer	0.000149	0.000263	CcSEcCtD
Rivastigmine—Dry mouth—Doxorubicin—testicular cancer	0.000148	0.000261	CcSEcCtD
Rivastigmine—Dyspepsia—Methotrexate—testicular cancer	0.000147	0.00026	CcSEcCtD
Rivastigmine—Hypotension—Epirubicin—testicular cancer	0.000146	0.000258	CcSEcCtD
Rivastigmine—Confusional state—Doxorubicin—testicular cancer	0.000146	0.000258	CcSEcCtD
Rivastigmine—Decreased appetite—Methotrexate—testicular cancer	0.000145	0.000257	CcSEcCtD
Rivastigmine—Oedema—Doxorubicin—testicular cancer	0.000145	0.000256	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000144	0.000255	CcSEcCtD
Rivastigmine—Fatigue—Methotrexate—testicular cancer	0.000144	0.000255	CcSEcCtD
Rivastigmine—Infection—Doxorubicin—testicular cancer	0.000144	0.000254	CcSEcCtD
Rivastigmine—Pain—Methotrexate—testicular cancer	0.000143	0.000253	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000142	0.000252	CcSEcCtD
Rivastigmine—Shock—Doxorubicin—testicular cancer	0.000142	0.000252	CcSEcCtD
Rivastigmine—Nervous system disorder—Doxorubicin—testicular cancer	0.000142	0.000251	CcSEcCtD
Rivastigmine—Thrombocytopenia—Doxorubicin—testicular cancer	0.000142	0.00025	CcSEcCtD
Rivastigmine—Insomnia—Epirubicin—testicular cancer	0.000141	0.00025	CcSEcCtD
Rivastigmine—Tachycardia—Doxorubicin—testicular cancer	0.000141	0.00025	CcSEcCtD
Rivastigmine—Skin disorder—Doxorubicin—testicular cancer	0.000141	0.000248	CcSEcCtD
Rivastigmine—Paraesthesia—Epirubicin—testicular cancer	0.00014	0.000248	CcSEcCtD
Rivastigmine—Hyperhidrosis—Doxorubicin—testicular cancer	0.00014	0.000247	CcSEcCtD
Rivastigmine—Dyspnoea—Epirubicin—testicular cancer	0.000139	0.000246	CcSEcCtD
Rivastigmine—Somnolence—Epirubicin—testicular cancer	0.000139	0.000246	CcSEcCtD
Rivastigmine—Anorexia—Doxorubicin—testicular cancer	0.000138	0.000244	CcSEcCtD
Rivastigmine—Feeling abnormal—Methotrexate—testicular cancer	0.000138	0.000243	CcSEcCtD
Rivastigmine—Dyspepsia—Epirubicin—testicular cancer	0.000138	0.000243	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000137	0.000241	CcSEcCtD
Rivastigmine—Decreased appetite—Epirubicin—testicular cancer	0.000136	0.00024	CcSEcCtD
Rivastigmine—Hypotension—Doxorubicin—testicular cancer	0.000135	0.000239	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000135	0.000239	CcSEcCtD
Rivastigmine—Fatigue—Epirubicin—testicular cancer	0.000135	0.000238	CcSEcCtD
Rivastigmine—Pain—Epirubicin—testicular cancer	0.000134	0.000236	CcSEcCtD
Rivastigmine—Constipation—Epirubicin—testicular cancer	0.000134	0.000236	CcSEcCtD
Rivastigmine—Urticaria—Methotrexate—testicular cancer	0.000133	0.000235	CcSEcCtD
Rivastigmine—Abdominal pain—Methotrexate—testicular cancer	0.000132	0.000233	CcSEcCtD
Rivastigmine—Body temperature increased—Methotrexate—testicular cancer	0.000132	0.000233	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000132	0.000233	CcSEcCtD
Rivastigmine—Insomnia—Doxorubicin—testicular cancer	0.000131	0.000231	CcSEcCtD
Rivastigmine—Paraesthesia—Doxorubicin—testicular cancer	0.00013	0.00023	CcSEcCtD
Rivastigmine—Dyspnoea—Doxorubicin—testicular cancer	0.000129	0.000228	CcSEcCtD
Rivastigmine—Feeling abnormal—Epirubicin—testicular cancer	0.000129	0.000228	CcSEcCtD
Rivastigmine—Somnolence—Doxorubicin—testicular cancer	0.000129	0.000227	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000128	0.000226	CcSEcCtD
Rivastigmine—Dyspepsia—Doxorubicin—testicular cancer	0.000127	0.000225	CcSEcCtD
Rivastigmine—Decreased appetite—Doxorubicin—testicular cancer	0.000126	0.000222	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000125	0.000221	CcSEcCtD
Rivastigmine—Fatigue—Doxorubicin—testicular cancer	0.000125	0.00022	CcSEcCtD
Rivastigmine—Urticaria—Epirubicin—testicular cancer	0.000124	0.00022	CcSEcCtD
Rivastigmine—Pain—Doxorubicin—testicular cancer	0.000124	0.000219	CcSEcCtD
Rivastigmine—Constipation—Doxorubicin—testicular cancer	0.000124	0.000219	CcSEcCtD
Rivastigmine—Body temperature increased—Epirubicin—testicular cancer	0.000124	0.000218	CcSEcCtD
Rivastigmine—Abdominal pain—Epirubicin—testicular cancer	0.000124	0.000218	CcSEcCtD
Rivastigmine—Hypersensitivity—Methotrexate—testicular cancer	0.000123	0.000218	CcSEcCtD
Rivastigmine—Asthenia—Methotrexate—testicular cancer	0.00012	0.000212	CcSEcCtD
Rivastigmine—Feeling abnormal—Doxorubicin—testicular cancer	0.000119	0.000211	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000118	0.000209	CcSEcCtD
Rivastigmine—Pruritus—Methotrexate—testicular cancer	0.000118	0.000209	CcSEcCtD
Rivastigmine—Hypersensitivity—Epirubicin—testicular cancer	0.000115	0.000204	CcSEcCtD
Rivastigmine—Urticaria—Doxorubicin—testicular cancer	0.000115	0.000203	CcSEcCtD
Rivastigmine—Abdominal pain—Doxorubicin—testicular cancer	0.000114	0.000202	CcSEcCtD
Rivastigmine—Body temperature increased—Doxorubicin—testicular cancer	0.000114	0.000202	CcSEcCtD
Rivastigmine—Diarrhoea—Methotrexate—testicular cancer	0.000114	0.000202	CcSEcCtD
Rivastigmine—Asthenia—Epirubicin—testicular cancer	0.000112	0.000198	CcSEcCtD
Rivastigmine—Pruritus—Epirubicin—testicular cancer	0.000111	0.000196	CcSEcCtD
Rivastigmine—Dizziness—Methotrexate—testicular cancer	0.000111	0.000195	CcSEcCtD
Rivastigmine—Diarrhoea—Epirubicin—testicular cancer	0.000107	0.000189	CcSEcCtD
Rivastigmine—Hypersensitivity—Doxorubicin—testicular cancer	0.000107	0.000188	CcSEcCtD
Rivastigmine—Vomiting—Methotrexate—testicular cancer	0.000106	0.000188	CcSEcCtD
Rivastigmine—Rash—Methotrexate—testicular cancer	0.000105	0.000186	CcSEcCtD
Rivastigmine—Dermatitis—Methotrexate—testicular cancer	0.000105	0.000186	CcSEcCtD
Rivastigmine—Headache—Methotrexate—testicular cancer	0.000105	0.000185	CcSEcCtD
Rivastigmine—Asthenia—Doxorubicin—testicular cancer	0.000104	0.000183	CcSEcCtD
Rivastigmine—Dizziness—Epirubicin—testicular cancer	0.000103	0.000183	CcSEcCtD
Rivastigmine—Pruritus—Doxorubicin—testicular cancer	0.000102	0.000181	CcSEcCtD
Rivastigmine—Vomiting—Epirubicin—testicular cancer	9.94e-05	0.000176	CcSEcCtD
Rivastigmine—Nausea—Methotrexate—testicular cancer	9.93e-05	0.000175	CcSEcCtD
Rivastigmine—Diarrhoea—Doxorubicin—testicular cancer	9.9e-05	0.000175	CcSEcCtD
Rivastigmine—Rash—Epirubicin—testicular cancer	9.86e-05	0.000174	CcSEcCtD
Rivastigmine—Dermatitis—Epirubicin—testicular cancer	9.85e-05	0.000174	CcSEcCtD
Rivastigmine—Headache—Epirubicin—testicular cancer	9.8e-05	0.000173	CcSEcCtD
Rivastigmine—Dizziness—Doxorubicin—testicular cancer	9.57e-05	0.000169	CcSEcCtD
Rivastigmine—Nausea—Epirubicin—testicular cancer	9.29e-05	0.000164	CcSEcCtD
Rivastigmine—Vomiting—Doxorubicin—testicular cancer	9.2e-05	0.000163	CcSEcCtD
Rivastigmine—Rash—Doxorubicin—testicular cancer	9.12e-05	0.000161	CcSEcCtD
Rivastigmine—Dermatitis—Doxorubicin—testicular cancer	9.12e-05	0.000161	CcSEcCtD
Rivastigmine—Headache—Doxorubicin—testicular cancer	9.07e-05	0.00016	CcSEcCtD
Rivastigmine—Nausea—Doxorubicin—testicular cancer	8.6e-05	0.000152	CcSEcCtD
